Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies: a monocentric retrospective study

被引：0
|
作者：
Sahloul, Oussama [1 ]
Louapre, Celine [1 ]
Beigneux, Ysoline [1 ]
Lubetzki, Catherine [1 ]
Maillart, Elisabeth [1 ]
Roux, Thomas [1 ]
机构：
[1] Pitie Salpetriere Univ Hosp, Dept Neurol, AP HP, CRC SEP, Paris, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P062/219
引用
收藏
页码：182 / 182
页数：1
相关论文
共 40 条
  • [31] No evident disease activity at 24 weeks in patients with relapsing MS treated with interferon β-1a SC vs. interferon β-1a IM in the EVIDENCE study
    Coyle, P. K.
    Fang, J.
    Hassan, A.
    Cha, C.
    Dangond, F.
    Reder, A. T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 113 - 113
  • [32] Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1-August 20, 2021): a retrospective observational monocentric study
    Guo, Yi
    Cowman, Kelsie
    Chang, Mei
    Bao, Hongkai
    Golia, Austin
    Mcsweeney, Terrence
    Bard, Linda
    Simpson, Roxanne
    Andrews, Erin
    Pirofski, Liise-Anne
    Nori, Priya
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [33] A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study
    Hirata, Shintaro
    Li, Wanying
    Defranoux, Nadine
    Cavet, Guy
    Bolce, Rebecca
    Yamaoka, Kunihiro
    Saito, Kazuyoshi
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2015, 25 (03) : 344 - 349
  • [34] Long term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis previously treated with interferon β-1a or disease modifying therapies: a post hoc analysis of the TRANSFORMS 4.5 year extension study
    Montalban, X.
    Barkhof, F.
    Comi, G.
    Hartung, H. -P.
    Kappos, L.
    Khatri, B.
    Pelletier, J.
    Kornyeyeva, E.
    Ritter, S.
    von Rosenstiel, P.
    Cohen, J.
    JOURNAL OF NEUROLOGY, 2013, 260 : S124 - S125
  • [35] Clinical efficacy and re-pregnancy outcomes of patients with previous cesarean scar pregnancy treated with either high-intensity focused ultrasound or uterine artery embolization before ultrasound-guided dilatation and curettage: a retrospective cohort study
    Wang, Xi
    Yang, Bing
    Chen, Wenzhi
    Chen, JinYun
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [36] Clinical efficacy and re-pregnancy outcomes of patients with previous cesarean scar pregnancy treated with either high-intensity focused ultrasound or uterine artery embolization before ultrasound-guided dilatation and curettage: a retrospective cohort study
    Xi Wang
    Bing Yang
    Wenzhi Chen
    JinYun Chen
    BMC Pregnancy and Childbirth, 23
  • [37] No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study
    Zivadinov, Robert
    Khan, Nasreen
    Korn, Jonathan R.
    Lathi, Ellen
    Silversteen, Jason
    Calkwood, Jonathan
    Kolodny, Scott
    Silva, Diego
    Medin, Jennie
    Weinstock-Guttman, Bianca
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (08) : 1431 - 1440
  • [38] Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study
    Horakova, Dana
    Uher, Tomas
    Krasensky, Jan
    Seidl, Zdenek
    Ribbens, Annemie
    Van Hecke, Wim
    Billiet, Thibo
    Koendgen, Harold
    Freudensprung, Ulrich
    Hyde, Robert
    Vaneckova, Manuela
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [39] Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study
    Bianca Weinstock-Guttman
    Jennie Medin
    Nasreen Khan
    Jonathan R. Korn
    Ellen Lathi
    Jason Silversteen
    Jonathan Calkwood
    Diego Silva
    Robert Zivadinov
    CNS Drugs, 2018, 32 : 75 - 84
  • [40] Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study
    Weinstock-Guttman, Bianca
    Medin, Jennie
    Khan, Nasreen
    Korn, Jonathan R.
    Lathi, Ellen
    Silversteen, Jason
    Calkwood, Jonathan
    Silva, Diego
    Zivadinov, Robert
    CNS DRUGS, 2018, 32 (01) : 75 - 84
1234